Shares of PB Fintech, the parent company of Policybazaar, and newly listed Turtlemint fell sharply on Thursday. The trigger was a consultation paper from the insurance regulator that could squeeze the commissions distributors earn.
PB Fintech hit its 20% lower circuit at ₹1,508.90, against Wednesday’s close of ₹1,886.30, and Turtlemint also dropped 20% to ₹109.04. Policybazaar’s parent didn’t stop there. PB Fintech tumbled as much as 30% to ₹1,320.10 on the NSE, its biggest single-day fall ever. It later extended the decline to about 32%, touching a low of ₹1,282.30. At the day’s low, over ₹24,500 crore had been wiped from its market capitalisation. Turtlemint’s fall took it to its lowest level since it listed in June 2026.
Why the stocks fell
The sell-off followed the Insurance Regulatory and Development Authority of India’s (IRDAI) consultation paper, “Recalibrating Economics of Insurance Distribution”. It proposes reforms covering distribution structures, expenses, commissions, market conduct and transparency. Investors focused on the commission proposals, since commissions from insurers are the main revenue source for distributors like Policybazaar and Turtlemint. The regulator has proposed hard commission caps and tighter expense limits for the sector, which threaten to compress the take rates of insurance distributors.
Brokerages were quick to put numbers on the risk. Jefferies estimates the caps could cut health, term and motor insurance commissions by between a third and a half. It says a 10% reduction in new business commission rates could translate to a 10-12% decline in earnings for PB Fintech and Turtlemint. Jefferies also noted that insurers have limited room to make up the difference through operating expenses, because of overall expense-of-management caps and the regulator’s stance that any payments to distributors count as commissions. Citi similarly warned that the caps could significantly tighten distribution economics, particularly in high-margin categories.
The pain spread beyond distributors
Insurers and lenders also took a hit. Max Financial Services, Canara HSBC Life and L&T Finance fell as much as 12% intraday, and ICICI Prudential Life and HDFC Life were also under pressure. Jefferies suggested that dips in SBI Life, Star Health and ICICI General could offer buying opportunities, given their relatively limited exposure to the proposals and potential market share gains.
What it means for Policybazaar
The proposal is a stress test for a company that has rarely had an easy run on the stock market. Policybazaar’s strong debut in 2021 was followed by a long slide. It has since grown into a profitable business, one that started out as an unicorn backed by Softbank and has long been valued on the back of its dominant position in online insurance sales. That growth story rests heavily on commission economics, which is why a regulatory proposal on payouts hit the stock so hard.
For now, this is only a consultation paper, and the final rules could differ from what has been proposed. The market, however, has decided to price in the worst case first.